12:00 AM
 | 
Nov 17, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Varisolve: Final Phase II data

A U.S. Phase II trial in 82 patients with right-to-left cardiac shunts showed that Varisolve did not cause cerebral, retinal or heart injury. MCA bubbles were detected in 74% of patients,...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >